Cancer Cause and Prevention Research in Louisiana
Cancer Cause and Prevention Research (93.393) awarded $7.0 million to recipients in Louisiana in 9 grants from fiscal 2021 to 2025, 0.2% of the program's national total. The Administrators of Tulane Educational Fund received the most, $3.7 million.
- Awarded in Louisiana$7.0 million
- Awards9
- Share of the program0.2%
- Rank among states39th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $1.2 million |
| FY 2022 | 5 | $1.8 million |
| FY 2023 | 4 | $1.1 million |
| FY 2024 | 3 | $1.4 million |
| FY 2025 | 4 | $1.5 million |
Recipients in Louisiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Administrators of Tulane Educational Fund | Colleges and universities | 5 | $3.7 million |
| Louisiana State University | Colleges and universities | 2 | $2.3 million |
| Louisiana State University Health Sciences Center New Orleans | Colleges and universities | 1 | $837,065 |
| Pennington Biomedical Research Center | Colleges and universities | 1 | $160,123 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Louisiana?
$7.0 million from fiscal 2021 to 2025, across 9 awards. Louisiana ranks 39th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Louisiana?
The largest recipient is The Administrators of Tulane Educational Fund, with $3.7 million in 5 awards. Next are Louisiana State University and Louisiana State University Health Sciences Center New Orleans.
Can organizations in Louisiana apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Louisiana
- Grants to States for Medicaid
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Highway Planning and Construction
- Education Stabilization Fund
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Broadband Equity, Access, and Deployment Program